TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06297291: Global Paradise System US Post Approval Study

Sponsor: ReCor Medical, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 1000 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$398,400

Rescue Site Savings

+$265,600

Unlock Full NCT06297291 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06297291 Rescue Dossier →